LAG3 was the most promising immune checkpoint after PD-1 and CTLA-4, and higher LAG3 and FGL1 expression promoted tumor growth by suppressing the immune microenvironment (Shi et al., 2021). The gene discussed is FGL1; the disease is neoplasm.